Omega Fund Iv, L.p. - Net Worth and Insider Trading
Omega Fund Iv, L.p. Net Worth
The estimated net worth of Omega Fund Iv, L.p. is at least $2 Million dollars as of 2024-09-20. Omega Fund Iv, L.p. is the 10% Owner of Paratek Pharmaceuticals Inc and owns about 779,802 shares of Paratek Pharmaceuticals Inc (PRTK) stock worth over $2 Million. Details can be seen in Omega Fund Iv, L.p.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Omega Fund Iv, L.p. has not made any transactions after 2016-06-27 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Omega Fund Iv, L.p.
Omega Fund Iv, L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Omega Fund Iv, L.p. owns 5 companies in total, including Replimune Group Inc (REPL) , Translate Bio Inc (TBIO) , and Kezar Life Sciences Inc (KZR) among others .
Click here to see the complete history of Omega Fund Iv, L.p.’s form 4 insider trades.
Insider Ownership Summary of Omega Fund Iv, L.p.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| REPL | Replimune Group Inc | 2018-07-19 | 10 percent owner |
| TBIO | Translate Bio Inc | 2018-07-02 | 10 percent owner |
| KZR | Kezar Life Sciences Inc | 2018-06-20 | 10 percent owner |
 | | 2016-06-27 | 10 percent owner |
| | 2014-02-11 | 10 percent owner |
Omega Fund Iv, L.p. Latest Holdings Summary
Omega Fund Iv, L.p. currently owns a total of 1 stock. Omega Fund Iv, L.p. owns 779,802 shares of Paratek Pharmaceuticals Inc (PRTK) as of June 27, 2016, with a value of $2 Million.
Latest Holdings of Omega Fund Iv, L.p.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PRTK | Paratek Pharmaceuticals Inc | 2016-06-27 | 779,802 | 2.23 | 1,738,958 |
Holding Weightings of Omega Fund Iv, L.p.
Omega Fund Iv, L.p. Form 4 Trading Tracker
According to the SEC Form 4 filings, Omega Fund Iv, L.p. has made a total of 0 transactions in Paratek Pharmaceuticals Inc (PRTK) over the past 5 years. The most-recent trade in Paratek Pharmaceuticals Inc is the acquisition of 461,538 shares on June 27, 2016, which cost Omega Fund Iv, L.p. around $6 Million.
Insider Trading History of Omega Fund Iv, L.p.
- 1
Omega Fund Iv, L.p. Trading Performance
GuruFocus tracks the stock performance after each of Omega Fund Iv, L.p.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Omega Fund Iv, L.p. is 7.27%. GuruFocus also compares Omega Fund Iv, L.p.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Omega Fund Iv, L.p. within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Omega Fund Iv, L.p.'s insider trading performs compared to the benchmark.
Performance of Omega Fund Iv, L.p.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 3.83 | | | | | |
| Relative Return to S&P 500(%) | -4.47 | | | | | |
Omega Fund Iv, L.p. Ownership Network
Omega Fund Iv, L.p. Owned Company Details
What does Replimune Group Inc do?
Who are the key executives at Replimune Group Inc?
Omega Fund Iv, L.p. is the 10 percent owner of Replimune Group Inc. Other key executives at Replimune Group Inc include Chief Financial Officer Emily Luisa Hill , Chief Medical Officer Konstantinos Xynos , and Chief Commercial Officer Christopher Sarchi .
Replimune Group Inc (REPL) Insider Trades Summary
Over the past 18 months, Omega Fund Iv, L.p. made no insider transaction in Replimune Group Inc (REPL). Other recent insider transactions involving Replimune Group Inc (REPL) include a net sale of 51,624 shares made by Pamela Esposito , a net sale of 30,332 shares made by Konstantinos Xynos , and a net sale of 41,467 shares made by Sushil Patel .
In summary, during the past 3 months, insiders sold 8,938 shares of Replimune Group Inc (REPL) in total and bought 0 shares, with a net sale of 8,938 shares. During the past 18 months, 282,095 shares of Replimune Group Inc (REPL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 282,095 shares.
Replimune Group Inc (REPL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Replimune Group Inc Insider Transactions
Omega Fund Iv, L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Omega Fund Iv, L.p.. You might contact Omega Fund Iv, L.p. via mailing address: 888 Boylston St., Suite 1111, Boston Ma 02199.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
